A specialized company in yeast-cultivated mushroom mycelium (truffle, Phellinus, and Reishi)
An environment has been created for the sale of health functional foods in pharmacies starting in 2025.
To systematically manage health functional foods sold in a disorganized manner, pharmacies will implement the repackaging of health functional foods, with pharmacists—experts in health and pharmaceuticals—at the forefront.
The shareholders of Rexpharm Co., Ltd. are pharmacists who actively introduced health functional foods in pharmacies since the 1990s.
Now, with the advent of a viral era caused by global warming, humanity faces a situation where even a slight weakening of immune function can expose individuals to viral diseases. Additionally, the super-aging population in our country has led to a rapid increase in cancer and diabetes patients.
As such, Rexpharm Co., Ltd. has prepared to support the repackaged sale of health functional foods in 25,000 pharmacies. We have cultivated Phellinus and Reishi mushroom mycelium and patented an enzyme extraction method to extract high-quality beta-glucan, aiming to enhance the immune capabilities of the entire population and help curb the increase in diabetes patients through the anti-diabetic effects of beta-glucan.
Rexpharm Co., Ltd. possesses the following strengths:
1. Sufficient resources to support the pharmacy repackaging of health functional foods.
2. A 15-ton mycelium cultivation facility.
3. A patent for the extraction method of beta-glucan from Phellinus mushrooms (Patent No. 10-1879506).
4. A patent for the extraction method of beta-glucan from Reishi mushrooms (Patent No. 1001817017), enabling us to produce high-quality beta-glucan.
Furthermore, we aim to establish a foundation for the company’s growth through large-scale production via truffle mycelium cultivation.
Rexpharm.Corp
CEO/Ph.D. in Pharmacy Chang-hoon Lee
